Table 4.
Variables correlated with the risk of not reaching at least ten years of follow-up
| Variables | Beta | SE | Wald | OR | 95.0% CI | P | |
|---|---|---|---|---|---|---|---|
| Lower | Upper | ||||||
| UNOS status 1-2A | 0.96 | 0.24 | 16.66 | 2.62 | 1.65 | 4.16 | < 0.0001 |
| Period 2002–2012 = Ref | – | – | – | 1.00 | – | – | – |
| Period 1982–1991 | 1.87 | 0.38 | 23.68 | 6.46 | 3.05 | 13.68 | < 0.0001 |
| Period 1992–2001 | 0.97 | 0.23 | 17.30 | 2.63 | 1.67 | 4.15 | < 0.0001 |
| Recipient age | 0.02 | 0.01 | 6.18 | 1.02 | 1.01 | 1.04 | 0.01 |
| Donor age | 0.01 | 0.01 | 5.00 | 1.01 | 1.00 | 1.03 | 0.03 |
| Constant | − 2.68 | 0.61 | 19.51 | 0.07 | – | – | < 0.0001 |
Hosmer–Lemeshow Test P = 0.72
Variables initially selected for constructing the model: Recipient age, donor-recipient blood iso-group, donor-recipient sex match, Caucasian ethnicity, UNOS status 1-2A, decade of transplant, split liver, HCC, HCV, HBV, HBV + HDV, alcohol, biliary cirrhosis, ALF, caval reconstruction technique, total ischemia time, donor age, induction with steroids, induction with immunoglobulin, cyclosporine, tacrolimus, azathioprine, derivatives of mycophenolic acid
SE standard error, OR odds ratio, CI confidence intervals, UNOS United Network for Organ Sharing, HCC hepatocellular carcinoma, HCV hepatitis C virus, HBV hepatitis B virus, HDV hepatitis D virus, ALF acute liver failure